Trademark: 77172736
Word
METATOR
Status
Dead
Status Code
604
Status Date
Wednesday, September 3, 2008
Serial Number
77172736
Mark Type
4000
Filing Date
Friday, May 4, 2007
Published for Opposition
Tuesday, April 8, 2008
Abandoned Date
Wednesday, September 3, 2008

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines

Trademark Events
Sep 3, 2008
Abandonment Notice Mailed - Inter Partes Decision
Sep 3, 2008
Abandonment - After Inter Partes Decision
Sep 3, 2008
Opposition Terminated No. 999999
Sep 3, 2008
Opposition Dismissed No. 999999
Aug 15, 2008
Teas Change Of Correspondence Received
Aug 1, 2008
Opposition Instituted No. 999999
Apr 30, 2008
Extension Of Time To Oppose Received
Apr 8, 2008
Published For Opposition
Mar 19, 2008
Notice Of Publication
Mar 3, 2008
Law Office Publication Review Completed
Feb 27, 2008
Approved For Pub - Principal Register
Feb 8, 2008
Teas/Email Correspondence Entered
Feb 8, 2008
Correspondence Received In Law Office
Feb 7, 2008
Assigned To Lie
Oct 5, 2007
Teas Response To Office Action Received
Sep 18, 2007
Notification Of Letter Of Suspension E-Mailed
Sep 18, 2007
Letter Of Suspension E-Mailed
Sep 18, 2007
Suspension Letter Written
Aug 27, 2007
Examiner's Amendment Entered
Aug 27, 2007
Assigned To Lie
Aug 27, 2007
Notification Of Examiners Amendment E-Mailed
Aug 27, 2007
Examiners Amendment E-Mailed
Aug 27, 2007
Examiners Amendment -Written
Aug 17, 2007
Assigned To Examiner
May 8, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24